CoChat

Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity

Open access
Davoren, Jennifer E., Garnsey, Michelle, Pettersen, Betty, Brodney, Michael A., Edgerton, Jeremy R., Fortin, Jean-Philippe, Grimwood, Sarah, Harris, Anthony R., Jenkinson, Stephen, Kenakin, Terry, Lazzaro, John T., Lee, Che-Wah, Lotarski, Susan M., Nottebaum, Lisa, O’Neil, Steven V., Popiolek, Michael, Ramsey, Simeon, Steyn, Stefanus J., Thorn, Catherine A., Zhang, Lei, Webb, Damien · 2017 · Journal of Medicinal Chemistry
Cited by 60

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Recent data demonstrated that activation of the muscarinic M 1 receptor by a subtype-selective positive allosteric modulator (PAM) contributes to the gastrointestinal (GI) and cardiovascular (CV) cholinergic adverse events (AEs) previously attributed to M 2 and M 3 activation. These studies were conducted using PAMs that also exhibited allosteric agonist activity, leaving open the possibility that direct activation by allosteric agonism, rather than allosteric modulation, could be responsible for the adverse effects. This article describes the design and synthesis of lactam-derived M 1 PAMs that address this hypothesis. The lead molecule from this series, compound 1 (PF-06827443), is a potent, low-clearance, orally bioavailable, and CNS-penetrant M 1 -selective PAM with minimal agonist activity. Compound 1 was tested in dose escalation studies in rats and dogs and was found to induce cholinergic AEs and convulsion at therapeutic indices similar to previous compounds with more agonist activity. These findings provide preliminary evidence that positive allosteric modulation of M 1 is sufficient to elicit cholinergic AEs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1021/acs.jmedchem.7b00597

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 59

  1. 10.1007/s12031-002-0031-5 · DOI
  2. 10.1176/appi.ajp.2008.08050769 · DOI
  3. 10.1001/archneur.1997.00550160091022 · DOI · Paper page
  4. 10.1176/appi.ajp.2008.06091591 · DOI · Paper page
  5. 10.1016/j.neuron.2010.11.018 · DOI · Paper page
  6. 10.1523/JNEUROSCI.2338-05.2005 · DOI · Paper page
  7. 10.1038/nn992 · DOI · Paper page
  8. 10.2147/NDT.S55104 · DOI · Paper page
  9. 10.1016/j.eururo.2007.12.007 · DOI
  10. 10.1016/j.archoralbio.2007.07.012 · DOI
  11. 10.1038/nature12735 · DOI · Paper page
  12. 10.1038/ng.2653 · DOI · Paper page
  13. 10.1073/pnas.0900903106 · DOI · Paper page
  14. 10.1021/jm200400m · DOI
  15. 10.1007/s00213-012-2788-8 · DOI
  16. 10.1124/jpet.115.226712 · DOI
  17. 10.2174/1568026614666140826120224 · DOI
  18. 10.1021/ml300280g · DOI
  19. 10.1016/j.bmcl.2014.01.012 · DOI
  20. 10.1021/ml100095k · DOI
  21. 10.1016/j.bmcl.2010.01.013 · DOI
  22. 10.1016/j.bmcl.2011.01.094 · DOI
  23. 10.1016/j.bmcl.2010.10.028 · DOI
  24. 10.1021/ml500055h · DOI
  25. 10.1016/j.bmcl.2015.11.053 · DOI
  26. 10.1021/acs.jmedchem.6b00544 · DOI · Paper page
  27. 10.1021/acschemneuro.6b00429 · DOI
  28. 10.1016/j.bmcl.2010.01.109 · DOI
  29. 10.1016/j.bmcl.2014.11.011 · doi:10.1016/j.bmcl.2014.11.011
  30. 10.1016/j.bmcl.2012.11.092 · DOI
  31. 10.1016/j.bmcl.2016.04.083 · DOI
  32. 10.1016/j.bmcl.2013.01.017 · DOI
  33. 10.1016/j.bmcl.2010.12.015 · DOI
  34. 10.1021/acschemneuro.6b00018 · DOI
  35. 10.1021/jm400540b · DOI · Paper page
  36. 10.1021/acs.jmedchem.5b01562 · DOI
  37. 10.1016/0006-8993(94)90017-5 · DOI
  38. 10.1073/pnas.94.24.13311 · DOI · Paper page
  39. 10.1046/j.1460-9568.2003.02588.x · DOI · Paper page
  40. 10.1124/jpet.115.226910 · DOI
  41. 10.1002/anie.200902262 · doi:10.1002/anie.200902262
  42. 10.1016/j.bmcl.2009.05.062 · DOI · Paper page
  43. 10.1021/jm0100990 · DOI · Paper page
  44. 10.1111/j.1753-5174.2010.00032.x · DOI
  45. 10.1152/jn.00686.2010 · DOI · Paper page
  46. 10.1038/bjp.2008.152 · DOI · Paper page
  47. 10.2174/156802609789753635 · doi:10.2174/156802609789753635
  48. 10.1111/j.1748-1716.1978.tb06302.x · DOI
  49. Luttrell L. M., 2002, J. Cell Sci., 115, 455, 10.1242/jcs.115.3.455 · DOI · Paper page
  50. 10.1098/rspb.1983.0093 · DOI · Paper page
  51. 10.1021/acs.biochem.6b00688 · DOI
  52. 10.1037/0735-7044.100.4.476 · doi:10.1037/0735-7044.100.4.476 · Paper page
  53. 10.1016/0165-0270(84)90007-4 · DOI · Paper page
  54. Patel V. R., 2011, J. Adv. Pharm. Technol. Res., 2, 81, 10.4103/2231-4040.79799 · DOI
  55. 10.1021/mp8000793 · DOI · Paper page
  56. 10.1016/j.jneumeth.2008.04.019 · DOI · Paper page
  57. 10.1038/nrd3649 · DOI · Paper page
  58. 10.3389/fnbeh.2014.00252 · DOI · Paper page
  59. 10.1124/mol.116.104737 · doi:10.1124/mol.116.104737

Cited by

See all 60

Metadata

Authors
Davoren, J. E., Garnsey, M., Pettersen, B., Brodney, M. A., Edgerton, J. R., Fortin, J.-P., Grimwood, S., Harris, A. R., Jenkinson, S., Kenakin, T., Lazzaro, J. T., Lee, C.-W., Lotarski, S. M., Nottebaum, L., O’Neil, S. V., Popiolek, M., Ramsey, S., Steyn, S. J., Thorn, C. A., Zhang, L., & Webb, D.
Venue
Journal of Medicinal Chemistry
Published
2017-07-26
Volume
60
Issue
15
Pages
6649-6663
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2622234382
Cited by
60
References
2
FWCI
2.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. https://app.cochat.ai/papers/10.1021/acs.jmedchem.7b00597
The paper
Davoren, J. E., Garnsey, M., Pettersen, B., Brodney, M. A., Edgerton, J. R., Fortin, J.-P., Grimwood, S., Harris, A. R., Jenkinson, S., Kenakin, T., Lazzaro, J. T., Lee, C.-W., Lotarski, S. M., Nottebaum, L., O’Neil, S. V., Popiolek, M., Ramsey, S., Steyn, S. J., Thorn, C. A., . . . Webb, D. (2017). Design and Synthesis of γ- and δ-Lactam M1 Positive Allosteric Modulators (PAMs): Convulsion and Cholinergic Toxicity of an M1-Selective PAM with Weak Agonist Activity. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b00597

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.